Moexipril: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{CMG}} ===Moexipril hydrochloride (Univasc=== ===Moexipril hydrochloride/Hydrochlorothiazide|Moexipril hydrochloride/Hydrochlorot..." |
|||
| Line 2: | Line 2: | ||
{{CMG}} | {{CMG}} | ||
===[[Moexipril | ===[[Moexipril Hydrochloride|Moexipril hydrochloride]] ([[Univasc]]）=== | ||
===[[Moexipril hydrochloride/Hydrochlorothiazide|Moexipril hydrochloride/Hydrochlorothiazide]] ([[Dutoprol]])=== | ===[[Moexipril hydrochloride/Hydrochlorothiazide|Moexipril hydrochloride/Hydrochlorothiazide]] ([[Dutoprol]])=== | ||
Revision as of 14:16, 29 May 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Moexipril hydrochloride (Univasc）
Moexipril hydrochloride/Hydrochlorothiazide (Dutoprol)
Overview
Moexipril Hydrochloride is an angiontensin converting enzyme inhibitor that is FDA approved for the treatment of hypertension. Adverse reactions include diarrhea, dizziness, cough and Influenza-like symptoms abnormal.
The active substance metoprolol is employed either as Moexipril hydrochloride or as Moexipril hydrochloride and hydrochloridethiazide.
Category
Angiontensin converting enzyme inhibitor